Literature DB >> 22293973

Stimulating axonal regeneration of mature retinal ganglion cells and overcoming inhibitory signaling.

Dietmar Fischer1.   

Abstract

Like other neurons of the central nervous system (CNS), retinal ganglion cells (RGCs) are normally unable to regenerate injured axons and instead undergo apoptotic cell death. This regenerative failure leads to lifelong visual deficits after optic nerve damage and is partially attributable to factors located in the inhibitory environment of the forming glial scar and myelin as well as to an insufficient intrinsic ability for axonal regrowth. In addition to its ophthalmological relevance, the optic nerve has long been used as a favorable paradigm for studying regenerative failure in the CNS as a whole. Findings over the last 15 years have shown that, under certain circumstances, mature RGCs can be transformed into an active regenerative state enabling these neurons to survive axotomy and to regenerate axons in the optic nerve. Moreover, combinatorial treatments overcoming the inhibitory environment of the glial scar and optic nerve myelin, together with approaches activating the intrinsic growth program, can further enhance the amount of regeneration in vivo. These findings are encouraging and open the possibility that clinically meaningful regenerationmay become achievable in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293973     DOI: 10.1007/s00441-011-1302-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  13 in total

1.  Chapter 5 - Restoring Vision to the Blind: Endogenous Regeneration.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

Review 2.  Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration.

Authors:  D Fischer
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

3.  CXCR4/CXCL12-mediated entrapment of axons at the injury site compromises optic nerve regeneration.

Authors:  Alexander M Hilla; Annemarie Baehr; Marco Leibinger; Anastasia Andreadaki; Dietmar Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

4.  The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells

Authors:  Colette Moses; Lachlan P G Wheeler; Chrisna J LeVaillant; Anne Kramer; Marisa Ryan; Greg S Cozens; Anil Sharma; Margaret A Pollett; Jennifer Rodger; Alan R Harvey
Journal:  eNeuro       Date:  2015-07-10

5.  Spatiotemporal alterations of presynaptic elements in the retina after high intraocular pressure.

Authors:  Jufang Huang; Lihong Zhou; Hui Wang; Jia Luo; Kun Xiong; Leping Zeng; Dan Chen
Journal:  Neural Regen Res       Date:  2012-06-05       Impact factor: 5.135

6.  Synergetic effects of ciliary neurotrophic factor and olfactory ensheathing cells on optic nerve reparation (complete translation).

Authors:  Dan-Ping Yin; Qing-Ying Chen; Lin Liu
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 5.135

Review 7.  Exploring Optic Nerve Axon Regeneration.

Authors:  Hong-Jiang Li; Zhao-Liang Sun; Xi-Tao Yang; Liang Zhu; Dong-Fu Feng
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Ischemic injury leads to extracellular matrix alterations in retina and optic nerve.

Authors:  Jacqueline Reinhard; Marina Renner; Susanne Wiemann; Daniel A Shakoor; Gesa Stute; H Burkhard Dick; Andreas Faissner; Stephanie C Joachim
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 9.  Neuroinflammation as Fuel for Axonal Regeneration in the Injured Vertebrate Central Nervous System.

Authors:  Ilse Bollaerts; Jessie Van Houcke; Lien Andries; Lies De Groef; Lieve Moons
Journal:  Mediators Inflamm       Date:  2017-01-19       Impact factor: 4.711

10.  Inflammatory stimulation preserves physiological properties of retinal ganglion cells after optic nerve injury.

Authors:  Henrike Stutzki; Christian Leibig; Anastasia Andreadaki; Dietmar Fischer; Günther Zeck
Journal:  Front Cell Neurosci       Date:  2014-02-12       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.